Perspective Therapeutics CATX
NYSE CATX
$2.75 +0.02 (+0.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Non Operating Investment Income (2018 - 2024)

Updated

Perspective Therapeutics (CATX) recorded Non Operating Investment Income of -$27,000 in Q4 2024, compared with $22,000 a year earlier.

Analysis

Perspective Therapeutics (CATX) Non Operating Investment Income (2018 - 2024) Analysis & Trends

Starting with Q4 2022, Perspective Therapeutics' Non Operating Investment Income history includes 4 quarters.

  • Across earlier years, Non Operating Investment Income came in at -$305,000 in FY2022 and -$9,000 in FY2021.
  • The Q4 2024 figure is the lowest quarterly Non Operating Investment Income since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Perspective Therapeutics 313.74 Mn 313.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -27,000.00
Dec 31, 2023 22,000.00
Mar 31, 2023 -22,000.00
Dec 31, 2022 -305,000.00
Mar 31, 2021 -2,000.00
Dec 31, 2020 -7,000.00
Mar 31, 2019 1,000.00
Dec 31, 2018 23,000.00
API Access

Perspective Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CATX&period=max&api_key=YOUR_API_KEY